We provide access to licensed providers who review your health profile to ensure the medication is appropriate for your specific needs
GLP-1 agents help many patients reach that threshold
Compounded GLP-1 users may be more likely to get meds through virtual platforms like Noom or Midi Health, many of which offer wraparound support (nutrition, self-tracking, coaching, support groups, etc.)
In 2024, semaglutide 2.4 mg (Wegovy) received FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity, based on the SELECT trial
And often, as was the case with imatinib, the $800 leukemia drug, the discounts still dont make the cost of a regular prescription affordable for the consumer
This is a glucagon receptor mediated effect that has no equivalent in tirzepatide therapy